About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Peptide Synthesis Service
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Cetrorelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Difelikefalin
Resources Center
FAQ
White Paper
Video
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
WHAT ARE YOU LOOKING FOR?
Home
About Us
About Us
Company Overview
Our Leadership
Global Supply Chain
IP Protection
Quality & Compliance
Environmental, Health and Safety
Solutions and Services
Solutions and Services
Discovery Synthesis
GMP Services
Generic APIs
FTE Services
Regulatory Affairs
Resources Center
Resources Center
FAQ
White Paper
Video
News
News
Company News
Blog
Careers
Contact Us
Catalog Peptides
US Operation
Email Us
Search
Home
News
Company News
7th CPC Symposium on Peptide Therapeutics
7th CPC Symposium on Peptide Therapeutics
PREV:
Chinese Peptide Company Inc. and UNC Lineberger Comprehensive Cancer Center Announce Neoantigen Peptide Collaboration
NEXT:
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.
News
Company News
Blog
Services
Discovery Synthesis
Peptide Synthesis Service
Oligonucleotide Synthesis
Cosmetic Peptides
GMP Services
GMP Manufacturing
GMP Production Capacity
GMP Compliance & Certification
Generic APIs
Leuprorelin Acetate
Triptorelin Acetate
Triptorelin Pamoate
Goserelin Acetate
Cetrorelix Acetate
Exenatide Acetate
Semaglutide
Terlipressin Acetate
Teduglutide
Linaclotide
Difelikefalin
FTE Services
Regulatory Affairs
Related Chinese Peptide Service
FRET Substrates
Linaclotide
Lipopeptides
Related Chinese Peptide News
01
Jun
2023
Demystifying Cosmetic Peptides: What You Need to Know
2020 DCAT Week – Drug, Chemical & Associated Technologies
Mar 23, 2019
Unlocking Hope: Triptorelin Pamoate's Role in Prostate Cancer Treatment
Dec 28, 2023
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist,[RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.
Feb 20, 2019
86-571-86737011
Your browser does not support VBScript!